New insights into the pathogenesis and therapy of sepsis and septic shock

Curr Clin Top Infect Dis. 2001:21:148-71.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Anticoagulants / pharmacology
  • Blood Coagulation / drug effects
  • Clinical Trials, Phase III as Topic
  • Cytokines / therapeutic use
  • Gram-Negative Bacteria / drug effects*
  • Gram-Negative Bacteria / pathogenicity
  • Gram-Positive Bacteria / drug effects*
  • Gram-Positive Bacteria / pathogenicity
  • Humans
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / metabolism*
  • Sepsis* / drug therapy
  • Sepsis* / microbiology
  • Sepsis* / mortality
  • Shock, Septic* / drug therapy
  • Shock, Septic* / microbiology
  • Shock, Septic* / mortality

Substances

  • Anti-Bacterial Agents
  • Anticoagulants
  • Cytokines
  • Lipopolysaccharides